Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
German Acute Hepatitis B Study
ISRCTN07772084Phase 2Completed
- Sponsor
- Leipzig University
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatitis B (HBV) comparing Lamivudine with Placebo (2 arms). Primary endpoints: Time until bilirubin below 2 mg/dL and Time to hospital discharge. Started Dec 2006; status: completed.
02
Drugs
lamivudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on ISRCTN07772084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN07772084.